CLINICAL_TRIALS
trial_result
· 2019-10-01
Clinical Trial Update: Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome [Phase 1, Phase 2]
Summary
Preliminary (Phase 1/2) trial updates on the effect of a high bolus dose of tirofiban given upstream in primary PCI for STEMI, status not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assiut University | Conditions: High Bolus Dose of Tirofiban | Phase 1, Phase 2 | Status: UNKNOWN